Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study

Pediatric Radiology

Volumn 45, Issue 4, 2015, Pages 582-589

  Ponrartana, Skorn ^a   Ramos Platt, Leigh ^a   Wren, Tishya Anne Leong ^a   Hu, Houchun Harry ^a   Perkins, Thomas Gardner ^b   Chia, Jonathan Mawlin ^b   Gilsanz, Vicente ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Diffusion tensor imaging; Duchenne muscular dystrophy; Magnetic resonance imaging; Muscle

Indexed keywords

ADOLESCENT; CHILD; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION TENSOR IMAGING; HUMAN; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PHYSICAL EXAMINATION; PILOT STUDY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; DIFFUSION TENSOR IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PHYSICAL EXAMINATION; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84939568501     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-014-3187-6     Document Type: Article

References (41)

1. Bushby K, Finkel R, Birnkrant DJ et al (2009) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93
2. Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928
3. Dubowitz V (1995) The muscular dystrophies. Muscle disorders in childhood. Saunders, London, pp 39–42
4. Kapsa R, Kornberg AJ, Byrne E (2003) Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2:299–310
5. Bogdanovich S, Perkins KJ, Krag TO et al (2004) Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med (Berl) 82:102–115
6. Tidball JG, Spencer MJ (2003) Skipping to new gene therapies for muscular dystrophy. Nat Med 9:997–998
7. Cyrulnik SE, Fee RJ, Batchelder A et al (2008) Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc 14:853–861
8. Escolar DM, Henricson EK, Mayhew J et al (2001) Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 24:787–793
9. Schrama PP, Stenneberg MS, Lucas C et al (2014) Intra-examiner reliability of hand-held dynamometry in the upper extremity: a systematic review. Arch Phys Med Rehabil. doi:10.1016/j.apmr.2014.05.019
10. Stern LM, Caudrey DJ, Perrett LV et al (1984) Progression of muscular dystrophy assessed by computed tomography. Dev Med Child Neurol 26:569–573
11. Scott OM, Hyde SA, Goddard C et al (1982) Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5:291–301
12. Brooke MH, Fenichel GM, Griggs RC et al (1983) Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103
13. Kilmer DD, Abresch RT, Fowler WM Jr (1993) Serial manual muscle testing in Duchenne muscular dystrophy. Arch Phys Med Rehabil 74:1168–1171
14. Brooke MH, Griggs RC, Mendell JR et al (1981) Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 4:186–197
15. Pourmand R (ed) (2004) Diagnostic tests in neuromuscular disease. Saunders, Philadelphia, PA
16. Marden FA, Connolly AM, Siegel MJ et al (2005) Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 34:140–148
17. Forbes SC, Walter GA, Rooney WD et al (2013) Skeletal muscles of ambulant children with Duchenne Muscular Dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology 269:198–207
18. Fischmann A, Hafner P, Gloor M et al (2013) Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 260:969–974
19. Finanger EL, Russman B, Forbes SC et al (2012) Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 23:1–10, ix
20. Gaeta M, Messina S, Mileto A et al (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 41:955–961
21. Gaeta M, Scribano E, Mileto A et al (2011) Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification–a feasibility study. Radiology 259:487–494
22. Kim HK, Laor T, Horn PS et al (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255:899–908
23. Wren TA, Bluml S, Tseng-Ong L et al (2008) Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 190:W8–12
24. Hollingsworth KG, Garrood P, Eagle M et al (2013) MR imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve 48:586–588
25. Kan HE, Scheenen TW, Wohlgemuth M et al (2009) Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 19:357–362
26. Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 15:456–467
27. Heemskerk AM, Strijkers GJ, Vilanova A et al (2005) Determination of mouse skeletal muscle architecture using three-dimensional diffusion tensor imaging. Magn Reson Med 53:1333–1340
28. Zaraiskaya T, Kumbhare D, Noseworthy MD (2006) Diffusion tensor imaging in evaluation of human skeletal muscle injury. J Magn Reson Imaging 24:402–408
29. Heemskerk AM, Damon DM (2007) Diffusion tensor MRI assessment of human skeletal muscle architecture. Curr Med Imaging Rev 3:152–160
30. Zhang J, Zhang G, Morrison B et al (2008) Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp Neurol 212:448–457
31. Kendall HO, Kendall FP, Wadsworth GE (1971) Muscles, testing and function. Williams and Wilkins, Baltimore, MD
32. Ponrartana S, Andrade K, Wren TA et al (2014) Repeatability of diffusion tensor imaging for the evaluation of lower extremity skeletal muscle. AJR Am J Roentgenol 202:W567–574
33. Reeder SB, McKenzie CA, Pineda AR et al (2007) Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25:644–652
34. Bley TA, Wieben O, Francois CJ et al (2010) Fat and water magnetic resonance imaging. J Magn Reson Imaging 31:4–18
35. Kim HK, Laor T, Horn PS et al (2010) Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment. Korean J Radiol 11:304–311
36. Kermarrec E, Budzik JF, Khalil C et al (2010) In vivo diffusion tensor imaging and tractography of human thigh muscles in healthy subjects. AJR Am J Roentgenol 195:W352–356
37. Sinha S, Sinha U, Edgerton VR (2006) In vivo diffusion tensor imaging of the human calf muscle. J Magn Reson Imaging 24:182–190
38. Galban CJ, Maderwald S, Uffmann K et al (2005) A diffusion tensor imaging analysis of gender differences in water diffusivity within human skeletal muscle. NMR Biomed 18:489–498
39. Budzik JF, Le Thuc V, Demondion X et al (2007) In vivo MR tractography of thigh muscles using diffusion imaging: initial results. Eur Radiol 17:3079–3085
40. Qi J, Olsen NJ, Price RR et al (2008) Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging 27:212–217
41. Williams SE, Heemskerk AM, Welch EB et al (2013) Quantitative effects of inclusion of fat on muscle diffusion tensor MRI measurements. J Magn Reson Imaging 38:1292–1297